Literature DB >> 3954873

Lesions of the amygdala, but not of the cerebellum or red nucleus, block conditioned fear as measured with the potentiated startle paradigm.

J Hitchcock, M Davis.   

Abstract

Rats were given 10 light-shock pairings on 2 successive days. At 24-48 hr following training, groups of rats received bilateral transection of the cerebellar peduncles, bilateral lesions of the red nucleus (which receives most of the cerebellar efferents), or bilateral lesions of the central nucleus of the amygdala. Control rats were sham operated. At 3-4 days after surgery, the rats were tested for potentiated startle (increased acoustic startle in the presence of the light previously paired with shock). Potentiated startle was blocked by lesions of the central nucleus of the amygdala. Transection of the cerebellar peduncles or lesions of the red nucleus did not block potentiated startle. A second experiment in which a visual prepulse test was used indicated that the blockade of potentiated startle observed in the animals with amygdala lesions could not be attributed to optic tract damage. A third experiment demonstrated that the absence of potentiation in the animals with amygdala lesions was not simply due to a lowered startle level ceiling, because these animals could show increased startle with increased stimulus intensity and with administration of strychnine, a drug that increases startle. Taken together, the results are consistent with the hypothesis that the amygdala is involved in fear conditioning, because potentiated startle is a measure of conditioned fear.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3954873     DOI: 10.1037//0735-7044.100.1.11

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  90 in total

1.  Injections of the NMDA receptor antagonist aminophosphonopentanoic acid into the lateral nucleus of the amygdala block the expression of fear-potentiated startle and freezing.

Authors:  M Fendt
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

2.  Anxiolytic effects of a novel group II metabotropic glutamate receptor agonist (LY354740) in the fear-potentiated startle paradigm in humans.

Authors:  Christian Grillon; Jeremy Cordova; Louise R Levine; Charles A Morgan
Journal:  Psychopharmacology (Berl)       Date:  2003-04-23       Impact factor: 4.530

3.  The development of fear learning and generalization in 8-13 year-olds.

Authors:  Catherine R Glenn; Daniel N Klein; Shmuel Lissek; Jennifer C Britton; Daniel S Pine; Greg Hajcak
Journal:  Dev Psychobiol       Date:  2011-11-09       Impact factor: 3.038

4.  The role of an amygdalo-nigrostriatal pathway in associative learning.

Authors:  J S Han; R W McMahan; P Holland; M Gallagher
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

5.  Sex difference in the expression of DNA methyltransferase 3a in the rat amygdala during development.

Authors:  M H Kolodkin; A P Auger
Journal:  J Neuroendocrinol       Date:  2011-07       Impact factor: 3.627

6.  Brain activity underlying emotional valence and arousal: a response-related fMRI study.

Authors:  Silke Anders; Martin Lotze; Michael Erb; Wolfgang Grodd; Niels Birbaumer
Journal:  Hum Brain Mapp       Date:  2004-12       Impact factor: 5.038

Review 7.  The Physiology of Fear: Reconceptualizing the Role of the Central Amygdala in Fear Learning.

Authors:  Orion P Keifer; Robert C Hurt; Kerry J Ressler; Paul J Marvar
Journal:  Physiology (Bethesda)       Date:  2015-09

8.  Biobehavioral threat sensitivity and amygdala volume: A twin neuroimaging study.

Authors:  Jens Foell; Isabella M Palumbo; James R Yancey; Nathalie Vizueta; Traute Demirakca; Christopher J Patrick
Journal:  Neuroimage       Date:  2018-10-28       Impact factor: 6.556

9.  Emotion potentiated startle in fragile X syndrome.

Authors:  Elizabeth C Ballinger; Lisa Cordeiro; Alyssa D Chavez; Randi J Hagerman; David Hessl
Journal:  J Autism Dev Disord       Date:  2014-10

10.  Effects of gastrin-releasing peptide agonist and antagonist administered to the basolateral nucleus of the amygdala on conditioned fear in the rat.

Authors:  Christine Mountney; Hymie Anisman; Zul Merali
Journal:  Psychopharmacology (Berl)       Date:  2008-06-18       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.